Actively Recruiting
Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant
Led by Istituto Ortopedico Rizzoli · Updated on 2026-02-17
15
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Limb amputation is a traumatic event that significantly reduces the ability to perform daily activities, impairs mobility, and lowers quality of life. In Italy, approximately 4 million people live with disabilities, with 1.2 million having motor disabilities. Among lower limb amputees (around 200,000), most are elderly, with amputations due to diabetic or vascular issues. Other groups include middle-aged adults (often victims of workplace accidents) and young individuals (victims of traffic accidents). Post-amputation rehabilitation mainly involves the use of prostheses, which, however, can cause skin problems due to the socket (the part that anchors the prosthesis to the residual limb). Among patients using a socket, 34-63% develop chronic skin issues and pain. Complications include excessive sweating, sores, abscesses, and irritation. Additionally, daily volume changes in the residual limb and long-term weight fluctuations further complicate the use of conventional prostheses. In the last two decades, research groups, assisted by experienced surgeons, have worked to develop implant solutions that bypass the socket and address these issues. One such solution is osteointegrated prostheses, which use the principle of osteointegration to anchor the prosthesis directly to the bone of the residual limb. A metal stem is surgically inserted into the medullary canal of the residual limb and fixed through bone growth, establishing a direct connection between the amputated limb and the external prosthesis. Osteointegrated prostheses are widely accepted worldwide as a valid alternative to socket prostheses, especially for young and active individuals with transfemoral, transtibial, transhumeral, or transradial amputations not caused by vascular issues. The key benefit of osteointegration is the restoration of load alignment along the anatomical and mechanical axis, improving control of the residual limb during walking, as well as overall functional capacity and quality of life. Other advantages include greater stability, enhanced sitting comfort, a wider range of hip movement, faster attachment and detachment of the prosthesis, and improved body perception. Additionally, the direct contact between the metal stem and the bone generates sensory feedback (osteoperception), allowing the patient to better control the amputated limb by perceiving ground contact through vibrations transmitted to the bone. Osteointegration offers the only viable alternative for prosthetic use in patients with a short residual limb, where conventional socket prostheses would not be suitable.
CONDITIONS
Official Title
Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects of both sexes, aged between 18 and 65 years
- Subjects with unilateral transfemoral amputation due to trauma, tumor, infection, or congenital defect
- Subjects already scheduled for osteointegrated prosthesis surgery for amputation
- Body mass index (BMI) less than 35 kg/m²
- Difficulty using traditional socket prosthesis due to pain, reduced mobility, short residual limb, skin infections, ulcers, or volume changes
- Subjects who have signed informed consent and reviewed study information
You will not qualify if you...
- Peripheral vascular diseases
- Pregnancy
- Rheumatoid arthritis
- Neurological deficits
- Amputation of the opposite limb
- Active infections
- Immunodeficiency
- Comorbidities or disabilities that may interfere with the study such as Multiple Sclerosis, Parkinson's disease, muscle tone disorders, malignant neoplasms
- Uncontrolled psychiatric conditions
- Cognitive deficits impairing task understanding (MMSE ≤ 24)
- Insufficient cooperation
- Residual limb bone length less than 15 cm
- Previous radiotherapy on the amputated limb
- Ongoing chemotherapy
- Smoking
- Uncontrolled diabetes
- Previous infections
- Additional joint prostheses on the same limb
- Osteoporosis with T-score of -2.5 or lower
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Rizzoli Orthopedic Institute
Bologna, Italy, 40136
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here